Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.60 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.60 |
| ▸ | ITGB2 | P05107 | 3/20 | 0.55 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.55 |
| ▸ | ITGAL | P20701 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.49 |
| ▸ | CA2 | P00918 | 3/20 | 0.49 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.48 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.48 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.45 |
| ▸ | GGT1 | P19440 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16364167 | 0.88 | SLC6A5 (0.62) | EPHX2SLC6A5ITGB2ICAM1ITGAL | |
| SCHEMBL27675779 | 0.85 | EPHX2 (0.60) | EPHX2SLC6A5ITGB2ICAM1ITGAL | |
| SCHEMBL3057446 | 0.85 | EPHX2 (0.60) | EPHX2SLC6A5ITGB2ICAM1ITGAL | |
| SCHEMBL29615190 | 0.85 | EPHX2 (0.60) | EPHX2SLC6A5ITGB2ICAM1ITGAL | |
| SCHEMBL19865798 | 0.85 | EPHX2 (0.60) | EPHX2SLC6A5ITGB2ICAM1ITGAL | |
| SCHEMBL14032422 | 0.85 | SLC6A5 (0.71) | EPHX2SLC6A5ITGB2ICAM1ITGAL | |
| SCHEMBL21089952 | 0.84 | SLC6A5 (0.59) | EPHX2SLC6A5ITGB2ICAM1ITGAL | |
| SCHEMBL21090525 | 0.84 | SLC6A5 (0.59) | EPHX2SLC6A5ITGB2ICAM1ITGAL | |
| SCHEMBL18381347 | 0.84 | SLC6A5 (0.61) | EPHX2SLC6A5ITGB2ICAM1ITGAL | |
| SCHEMBL29071832 | 0.83 | SLC6A5 (0.63) | EPHX2SLC6A5ITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220162156-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME | Cellix Bio Provate Limited (IN) | 2022-05-26 | — | — | US | disclosed |
| US-11078154-B2 | Compositions and methods for the treatment of irritable bowel syndrome | CELLIX BIO PRIVATE LIMITED (IN) | 2021-08-03 | — | — | US | disclosed |
| US-20190177267-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME | CELLIX BIO PRIVATE LIMITED (IN) | 2019-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162156-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME | SI, SLC10A2, F5 | EPHX2 999/4885SLC6A5 360/4885ITGB2 1771/4885 |
| US-11078154-B2 | Compositions and methods for the treatment of irritable bowel syndrome | SI, SLC10A2, ALPI | EPHX2 1726/4885SLC6A5 100/4885ITGB2 2624/4885 |
| US-20190177267-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME | SI, SLC10A2, F5 | EPHX2 999/4885SLC6A5 360/4885ITGB2 1771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.